Beckwith-Wiedemann Syndrome and Ambiguous Genitalia
Beckwith-Wiedemann syndrome (BWS) can be associated with genital abnormalities, including ambiguous genitalia, though this is not a classic feature of the syndrome. The association is rare but documented in the literature, and clinicians should be aware of this potential manifestation when evaluating patients with BWS.
Clinical Evidence for Genital Abnormalities in BWS
Documented Associations
The literature provides clear evidence that genital abnormalities can occur in BWS:
- Male genital anomalies are more commonly reported, with cryptorchidism and hypospadias occurring in approximately 80% of male children with BWS in some series 1
- Ambiguous genitalia has been documented in case reports, including a notable case of a 46,XX patient with BWS who presented with ovotesticular disorder and ambiguous genitalia 2
- Clitoromegaly has been reported, including a recent case where a female neonate with BWS presented with prominent labia majora, hyperpigmented and enlarged clitoris that initially mimicked congenital adrenal hyperplasia (CAH) 3
Important Clinical Distinction
A critical caveat: The clitoromegaly and genital changes in the documented BWS case resolved spontaneously by six months without surgical intervention 3. This case initially presented with features suggesting CAH (elevated testosterone and 17-hydroxyprogesterone, hyperpigmented genitalia), but these were transient and related to BWS rather than true CAH. This highlights the importance of:
- Not rushing to diagnose CAH in BWS patients with genital abnormalities
- Considering BWS molecular testing when genital abnormalities occur alongside other overgrowth features
- Recognizing that some genital changes may be transient
Classic BWS Features to Look For
When evaluating for BWS, the classic features include 4:
- Major features: Macrosomia, macroglossia, omphalocele/umbilical hernia, hemihyperplasia, facial nevus flammeus
- Tumor predisposition: Wilms tumor, hepatoblastoma, neuroblastoma
- Metabolic: Neonatal hypoglycemia due to hyperinsulinism
- Renal: Nephromegaly, structural kidney abnormalities
Molecular Basis
BWS results from dysregulation at chromosome 11p15.5, involving imprinted genes (H19, IGF2, CDKN1C). The documented case of BWS with ambiguous genitalia showed hypomethylation at KCNQ1OT1:TSS-DMR (IC2) 3, and the ovotesticular case had a 46,XX karyotype without Y-chromosome sequences 2. This suggests that imprinting dysregulation may affect gonadal and genital development pathways, though the mechanism remains incompletely understood.
Clinical Approach
When encountering a patient with suspected BWS and genital abnormalities:
- Document all BWS features systematically (macroglossia, abdominal wall defects, overgrowth parameters)
- Obtain molecular testing for 11p15.5 alterations using methylation-specific testing
- Evaluate for CAH with appropriate biochemical testing, but recognize this may be a false lead in BWS
- Consider observation before surgical intervention for genital abnormalities, as some may resolve spontaneously
- Perform comprehensive urologic evaluation including assessment for cryptorchidism, hypospadias, and structural abnormalities 5
Surveillance Implications
The presence of genital abnormalities does not change the core BWS surveillance recommendations, which focus on tumor screening 4:
- Renal ultrasound every 3 months from birth through age 7-8 years for Wilms tumor
- Abdominal ultrasound and alpha-fetoprotein every 3 months from birth through age 4 years for hepatoblastoma
- Evaluation by cancer predisposition specialists when possible
Bottom line: While ambiguous genitalia is not a cardinal feature of BWS, it can occur and should prompt consideration of BWS when other overgrowth features are present. The genital abnormalities may be transient and should not be confused with CAH or other primary disorders of sexual development.